Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATV-PG and Amodiaquine Safety and PK in Healthy Adults
NCT04002687Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of atovaquone + proguanil and amodiaquine in malaria, sponsored by Medicines for Malaria Venture. Started Apr 2019; status: completed.
02
Drugs
atovaquone + proguanilamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04002687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002687.